Clinical impact of prophylactic antibiotic treatment for self-expandable metallic stent insertion in XXXX with malignant @entity14 .

@entity1 @entity2259 @entity1850 @entity14 @entity166 @entity1851
Purpose. The aim of this study was to determine the efficacy of prophylactic antibiotics (PA) for reducing the @entity166 and the potential risk factors responsible for the @entity166 after stent insertion for malignant @entity14 . Methods. We performed a retrospective review of 224 @entity1 who underwent self-expandable metallic stent (SEMS) insertion for malignant @entity14 from May 2004 to December 2012. Results. There were 145 @entity1 in the PA group and 79 in non-PA group. The @entity1851 level in PA group was significantly higher than that in non-PA. Abdominal tenderness and mechanical ileus were significantly more frequent in PA group than those in non-PA. The frequency of post-SEMS insertion fever, @entity1850 ( @entity1850 ), and @entity2259 was not significantly different between PA and non-PA groups. In multivariate analysis, the @entity1851 level was risk factor related to post-SEMS insertion @entity1850 . However, in propensity score matching analysis, there was no independent risk factor related to post-SEMS insertion fever, @entity1850 , and @entity2259 . Conclusion. The use of PA in @entity1 with malignant @entity14 may be not effective to prevent the development of @entity166 after SEMS insertion.
